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Abstract
Background: Segmental duplications are an abundant source for novel gene functions and evolutionary
adaptations. This mechanism of generating novelty was very active during the evolution of primates particularly in
the human lineage. Here, we characterize the evolution and function of the SPATA31 gene family (former
designation FAM75A), which was previously shown to be among the gene families with the strongest signal of
positive selection in hominoids. The mouse homologue for this gene family is a single copy gene expressed during
spermatogenesis.
Results: We show that in primates, the SPATA31 gene duplicated into SPATA31A and SPATA31C types and broadened
the expression into many tissues. Each type became further segmentally duplicated in the line towards humans with
the largest number of full-length copies found for SPATA31A in humans. Copy number estimates of SPATA31A based on
digital PCR show an average of 7.5 with a range of 5–11 copies per diploid genome among human individuals. The
primate SPATA31 genes also acquired new protein domains that suggest an involvement in UV response and DNA
repair. We generated antibodies and show that the protein is re-localized from the nucleolus to the whole nucleus
upon UV-irradiation suggesting a UV damage response. We used CRISPR/Cas mediated mutagenesis to knockout
copies of the gene in human primary fibroblast cells. We find that cell lines with reduced functional copies as well as
naturally occurring low copy number HFF cells show enhanced sensitivity towards UV-irradiation.
Conclusion: The acquisition of new SPATA31 protein functions and its broadening of expression may be related to the
evolution of the diurnal life style in primates that required a higher UV tolerance. The increased segmental duplications
in hominoids as well as its fast evolution suggest the acquisition of further specific functions particularly in humans.
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Background
Gene duplications are a common source of evolutionary
novelties [1]. Genome sequence analysis has shown that
chromosomal fragments can become duplicated either
in tandem or dispersed across chromosomes. The generic
term “segmental duplications” has been coined for this
form of duplication, and it is thought to have been particu-
larly active in the primate lineage—especially in humans
[2]. These duplications are associated with rapid structural
changes, chromosomal instability and evolutionary rear-
rangements. The size of the duplicated regions ranges be-
tween one to several hundred kilobases. Approximately 430
delimited blocks of the human genome have been identified
as regions for multiple duplications during hominoid evolu-
tion. In general, segmental duplications comprise about 5%
of the human genome [2] and [3].
Some of the segmentally duplicated genomic regions
are clustered around “core” duplication blocks (core
duplicons) [4, 5]. The corresponding genes and gene
families encoded by these core duplicons are different
from classical segmentally duplicated gene families. Most
of these core sequences show ubiquitous or global pat-
terns of expression versus the ancestral locus [4]. Some
of the most variable human CNV genes correspond to
recently evolved gene families with embedded human
core duplicons [6, 7]. Hence, it seems possible that gene
families found with such core duplicons may be associ-
ated with specific adaptations during the evolution of
the human lineage within the primate phylogeny [8–10].
However, only one of these recently duplicated gene
families, TBC1D3, has been functionally characterized so
far and was found to regulate EGF signaling [11–13].
We focus here on the SPATA31 gene family (previ-
ously known as FAM75A), which is one of the fastest
evolving gene families in the human lineage [8]. It be-
longs to the human core duplicon families [4], and it
evolved from a single copy gene in mammals. Spata31
in mice (previously known as VAD1.3) interacts with
syntaxin and beta actin [14]. Knock-out mice are infer-
tile due to a reduced number of sperm cells suggest-
ing a role of the gene in mouse spermatogenesis [15].
We present here a comparative analysis between
mice, old world monkeys (macaque) and hominoids
(including human). We show that the SPATA31 gene
family expanded within the great apes by segmental
duplication from one copy in mice to two copies in
macaque and to multiple functional and non-
functional copies along chromosome 9 in hominoid
primates and humans. The SPATA31 gene in primates
acquired new upstream sequences that have led to
broader expression and new protein domains suggest-
ing an involvement in sensing and/or repairing UV
damage. We provide experimental evidence in cell
cultures that support this hypothesis.
Results and discussion
Gene duplication patterns
We conducted a detailed analysis of gene structure evo-
lution and duplication patterns of SPATA31 based on
genome sequence comparisons. The mouse harbors a
single copy of the Spata31 gene on chromosome 13. In
the macaque, there are two copies of SPATA31: type A
and type C. Both expanded along chromosome 9 in
humans (Fig. 1). There are other members of the gene
family (SPATA31D and E) sharing a FAM75A domain,
but they are otherwise much more diverged (Additional
File 1) and are not considered further here.
Type A has seven segmental duplications in humans
(numbers based on human genome build hg38), of
which one is a clear pseudogene due to multiple stop co-
dons (P1Ψ). Another encodes a truncated protein (P2)
due to a frameshift mutation resulting in a premature
stop codon in exon 4 (Fig. 1). Note that the annotation
around SPATA31A5 and SPATA31A7 is uncertain be-
cause short non-sequenced regions interrupt the region.
Type C has two copies in the human genome—each is
preceded by a duplication of the first exon including the
promoter sequence (Fig. 1). However, these additional
promoters do not appear to initiate transcripts. The gene
lengths and the protein coding regions of SPATA31
genes differ between A and C types. The predicted mo-
lecular weights are 157 kD for the A type (A1) and 130
kD for the C type (C1).
To trace the expansion of the family, we assessed copy
numbers in fully sequenced genomes of sequenced indi-
viduals from macaque, orangutan, chimps and twelve
humans including Us_Ishim, Denisovan and Neandertal.
The results show that there was on average a progressive
increase of segmental duplications of the SPATA31 gene
locus towards humans (Additional File 2).
A detailed comparison of the promoter regions includ-
ing LINE/L1 (MD and MER31A) elements revealed that
there are two different general promoter structures
shared by all SPATA31A and SPATA31C genes respect-
ively (Fig. 2 and Additional File 3). In particular, the pro-
moter region of SPATA31C was subjected to multiple
rounds of rearrangement resulting in a composite pro-
moter structure consisting of three LINE/L1, MD,
MER31A, PA10, three AluY and one ERV1 elements. In
contrast, the functional SPATA31A promoters are com-
posed of LINE/L1-P3 and PA10 retroviral elements
(Additional File 3). The main expansion of the PA10
element occurred about 65 Mya and the expansion of
the P3 element occurred about 35 Mya (reviewed in [16]
and [17]). Accordingly, no P3 element is detected in the
promoter regions of New World Monkeys. An insertion
of a CCCCCT simple repeat is observed in gorillas,
chimpanzees and humans at the time where the main
expansion of the family is observed. Thus, we propose
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that the promoter region of SPATA31A was restructured
in a stepwise manner by integration of LINE and a
CCCCCT simple repeat within the primate phylogeny
(Fig. 2).
Fig. 2 also includes phylogenetic comparisons of the A
and C-type copies in humans and chimpanzees. The re-
spective duplicated copies for each type are more similar
within each species than between the two species. This
is a clear sign of concerted evolution of the gene family
within each species [18]. In case of segmentally dupli-
cated genes, this would occur most likely by frequent
gene conversion events such that the duplicated copies
retain higher similarity within their evolutionary lineage.
Protein domain evolution
Motif scans and multiple alignment analysis (Additional
File 4) predict that there are several domain structures
present in SPATA31 proteins and that they differ be-
tween the subtypes and between primates (represented
by human) and mouse (Fig. 3; Additional File 5). All
share a FAM75A domain in the middle, a nuclear
localization signal in the N-terminal part of the protein
and a PCNA-interacting domain at the C-terminus. The
primate genes have a cryptochrome/photolyase domain
and a proline rich region. SPATA31A has a DNA topo-
isomerase domain and a further nuclear localization sig-
nal in the middle of the protein. The mouse SPATA31
protein has an alkaline phosphatase and a TRR-like do-
main that is not found in the primate proteins (Fig. 3).
The SPATA31 gene family also shows similarities to
Epstein Barr Virus (EBV)–BPLF1 and CRY2 proteins
(Additional File 6), and we found through antibody
staining (see below) partial co-localization with CRY2
protein (Additional File 7). CRY2 is one of the circadian
clock proteins involved in blue light-dependent regula-
tion of the circadian feedback loop [19]. Cryptochromes
play an important role in intrinsic apoptosis induced by
UV mimetic and radiometric compounds [20]. EBV-
BPLF1 protein has been implicated to interact with
PCNA and to delay the DNA trans-lesion synthesis
(TLS) repair mechanism [21]. The TLS repair mechan-
ism was also shown to be important during UV
irradiation-induced DNA damage repair [22]. Hence, the
N-terminal region of the SPATA31 proteins acquired
several important functional domains compatible with
the acquisition of an UV response when compared to
the mouse SPATA31 proteins.
Copy number variation of SPATA31A
To determine copy number variation for the SPATA31A
genes in human populations we used genomic DNA
panels for a subset of individuals that were also used in
the 1,000 Genomes Project. We genotyped 322 samples
from the MGP00001 (Finnish in Finland), MGP00002
(Han Chinese South), MGP00008 (Luhya in Webuye,
Kenya) and MGP00013 (Yoruba in Ibadan, Nigeria)
panels from the NHGRI Repository at Cornell using
digital PCR with SPATA31A-specific primers. We found
Fig. 1 SPATA31 gene family expansion in humans. The gene structure and chromosome localization of SPATA31 genes based on the human
reference (hg38), rhesus macaque (rheMac3) and mouse (mm10) genomes are shown. The mouse harbors a single copy that has duplicated and
diverged into an A and a C type in macaque. Further segmental duplications are found in humans on chromosome 9
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on average around 7.5 copies per diploid genome, with a
range between 4.5 to 10.8 copies on the extremes (Fig. 4).
There were no obvious differences between the means
of each population, but there were differences in the
breadth of distribution with the highest in the Chinese
population (mean and standard deviation for Chinese
(7.24 and 1.24), Finnish (7.61 and 0.98), Kenyan (7.62
and 0.71), Yoruban (7.62 and 0.85)) (Fig. 4).
RNA and protein expression
We used RT-PCR to assess the expression of SPATA31 (A
and C type combined) in different mouse and human tis-
sues. We found that the mouse expresses the gene only in
the testis, while humans show expression in multiple tis-
sues (Fig. 5a). Such an expansion of expression into other
tissue types was also seen for the segmentally duplicated
Morpheus [23] and LRRC37 genes [10], [24] and in pri-
mates [25]. The differences in expression may be associ-
ated with the observed restructuring of the SPATA31A/C
gene and the promoter region by repetitive elements dur-
ing the evolution of primates (see above). However, quan-
titative PCR showed that even in humans the highest level
of expression is still in the testis—expression in other tis-
sues is still quite low (Additional File 8).
We raised an antibody against peptides shared by the
A and C types to assess the protein localization at the
Fig. 2 Evolutionary emergence of the human SPATA31 gene promoter structures. Phylogenetic reconstruction of full length SPATA31 proteins (exon4 -
longest coding exon) in different primates, cat, dog, rat and mouse species using the NJ method [43] with bootstrap values (500 replicates) indicated
at the branches [44]. Species names are: rat (R. norvegicus), mouse (Mus musculus domesticus), cat (F. catus), dog (C. familiaris), tarsius (T. syrichta),
marmoset (C. jacchus), saimiri (S. boliviensis), baboon (P. hamadryas), rhesus macaque (M. mulatta), gibbon (N. leucogenys), orangutan (P. pygmaeus),
gorilla (G. gorilla), chimpanzee (P. troglodytes) and human (H. sapiens). Repetitive elements LINE/L1-PA10 (pink), LINE/L1-P3 (red) and (CCCCCT)n (blue)
that were found within the SPATA31A promoter region are indicated with an arrow to show approximate integration time
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sub-cellular level (see Additional File 9 for documenta-
tion of the specificity of the antibody). We found that
during mitosis the SPATA31 protein accumulates
around the spindle (Additional File 10). In lung and
sinus tissue, the protein is mostly expressed in the epi-
thelial layer, but almost all of the cells show expression
in tonsil tissue (Additional File 11). We focused most of
the further analysis on human foreskin fibroblasts (HFF),
which represent primary and non-immortalized cells of
the ectoderm. Here, SPATA31 proteins are primarily lo-
calized to the nucleus with an enhanced staining seen in
the nucleolus—especially under dark conditions (Fig. 5b).
Based on the domain and similarity analyses above, we
reasoned that SPATA31 protein may be involved directly
or indirectly in the repair pathway of UV-induced DNA
damage and/or for the recruitment of the DNA repair
molecules to damaged sites via its PCNA interaction do-
main. Therefore, we exposed various human cell lines to
different strength and time intervals of UVC light. We
found a consistent shift and/or upregulation from nucle-
olar localization to a spread across the entire nucleus in
these experiments (Fig. 5b and Additional File 12). This
effect was also seen in other proteins involved in UV
damage repair [26].
SPATA31 function
To investigate the molecular function of SPATA31A/C
genes, we targeted exon 1 of the SPATA31A/C genes
via CRISPR/Cas mediated mutagenesis [27, 28] (Add-
itional File 13) in human foreskin fibroblast cells
(HFF). We did not expect to obtain a full knockout
because we were targeting a multi-copy gene; rather,
the goal was a reduction in functional gene numbers.
To estimate the types and frequencies of mutations
induced across different copies, we amplified frag-
ments around the expected lesion and sequenced
them via Illumina sequencing. This allowed us to
identify single cell clones with low and high frame
Fig. 3 Domain patterns of SPATA31 proteins. Protein domain patterns of mouse Spata31 (NM_030047.2), human SPATA31A1 (NM_001085452) and
human SPATA31C1 (NM001145124) based on comparative genomics, smart protein database (http://smart.embl-heidelberg.de/) and motif search
(http://myhits.isb-sib.ch/cgi-bin/motif_scan). Protein domains are depicted with colored boxes (right). Note that the human domain structure is
the same as in the other primates including macaque. See Additional File 5 for details of the domain descriptions and definitions
Fig. 4 Copy number variation of SPATA31A in human populations. Copy numbers of individuals were estimated based on digital PCR and then
binned into number classes (see Additional File 15 for detailed data)
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shift mutation numbers (Additional File 14). For fur-
ther analysis, we selected one of the best growing cell
lines from each class, Cl1 (low number of frameshifts)
and Cl2 (high number of frameshifts) using untreated
HFF cells as control.
We tested whether the mutated cell lines would
show an effect with respect to UV-induced cell dam-
age and death. Both the Cl1 and the Cl2 cells had el-
evated sensitivity to UVC treatment compared to
control. Stronger effects were seen in the Cl2 cells
(Fig. 6a). Using digital PCR analysis we found that
the two different HFF cell lines had incidentally a
natural difference in copy number. Cell line HF2450
has eight copies of SPATA31A and three of SPA-
TA31C; cell line HF2703 has nine SPATA31A copies
and four SPATA31C (numbers refer to diploid copy
number). We compared these two cell lines in the
same UV damage test and found that the one with
more copies is somewhat less sensitive to UVC irradi-
ation (Fig. 6b).
Fig. 5 Expression analysis of SPATA31 RNA and protein within human primary fibroblast (HFF) cells. a RT-PCR analysis on cDNA isolated from total
human RNA (Clontech) and from Mouse RNA. The PCR primers were designed to amplify the highly conserved region within the long coding
exon for human. For mouse, we amplified a region spanning exons 1–3. The UBE1 gene was used as control. Quantitative PCR for the same tissue
samples is shown in Additional File 8. b Antibody staining of HFF cells with fixation under dark conditions versus a treatment with 200 J/m2 UVC
and 24 h further growth at two different magnifications (63x and 100x). Nuclei in the first column are stained with DAPI (blue), and SPATA31 staining is
shown in the second column (red). In the third column, the green staining in the 63x pictures is cellular cytoskeleton detected with an antibody
against tubulin and in the 100x columns the nucleolus with an antibody against Per2 [45]. See Additional File 12 for further quantification of SPATA31
response of re-localization upon different exposure to UVC. We noted some variation of relative SPATA31 protein localization between cytoplasm and
the nucleus depending on the cell cycle and fixation protocol as well as dark–light conditions during fixation similar to other UV response proteins
such as H2Ax (reviewed in [46] and see Methods)
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Conclusions
The spermatogenesis phenotype of Spata31 knockout in
mice [15] suggests that the ancestral function of
SPATA31 is in the pathway of sperm formation. It is
currently unknown whether it retained this function
in humans, but the high expression in human testis
points to an involvement in spermatogenesis as well.
However, SPATA31 has clearly also acquired new
functions in the primate lineage. Its acquisition of a
cryptochrome/photolyase domain may allow it to
sense UV light, although photolyase domains are so
far only known from circadian clock functions where
they sense blue light [29]. Further, it may recruit
other DNA repair genes through its topoisomerase
domain and the PCNA interacting motif by opening
the chromatin structure.
Given that increasing exposure to UV light would
have played a role in primate and hominoid diurnal
evolution, it is likely that the original acquisition of
new functions is connected to the increased exposure
to sunlight. The further expansion into multiple copies
in the line towards humans may have had the same
reason. Humans in particular got exposed to more UV
light in conjunction with loosing their body hair. But
this would have been dependent on skin color and the
parts of the world where they lived. This could explain
why there is still copy number variation at this locus.
However, these explanations remain necessarily specu-
lative and require deeper population analysis in
humans as well as further functional studies.
Methods
Nomenclature
The naming of the paralogous SPATA31 variants follows
the Hugo Gene Nomenclatures (HGNC) (http://www.ge-
nenames.org). The corresponding gene names are also
implemented in the GRCh38/hg38 reference assembly of
the human genome [30].
RT-PCR
Total RNA used for cDNA preparation was extracted
from mouse tissues using the RNeasy kit (Qiagen). Total
RNA from human tissues was purchased from Clontech
(Cat No: 636643). Polyadenylated mRNA was isolated
using the Oligotex mRNA mini kit (Qiagen). cDNA was
prepared using the Reverse Transcriptase PCR kit (Fer-
mentas) according to manufacturers recommendation
with the exception of: Odt and random hexamer primers
were added at equal concentration and the reaction mix-
ture was incubated for 60 min and immediately used for
subsequent RT-PCR or RACE-PCR. UBE1 was used as
positive control. PCR was performed in 20 μL reactions
composed of 0.8 μL of a 10 μM dilution of the forward
primer and reverse primer, 10 μL of PCR Master Mix
(Roche −11636103001). See Additional File 16 for the
PCR conditions and primer sequences.
Quantitative real-time PCR
SPATA31 transcripts were analyzed by a quantitative
PCR assay using the ABI SYBR Green System (Applied
Biosystems 7500 Real Time PCR System) with primers
directed against the last coding exon (exon 4). The
amount of measured transcripts was normalized to the
amount of the Ef1alpha transcript. See Additional File
16 for the real-time PCR conditions.
5’RACE-PCR
Single-stranded cDNA (described above) was purified by
using a rapid PCR purification kit (Roche). The terminal
deoxynucleotidyl transferase (TdT) reaction was pre-
pared as follows: 16.5 μL cDNA, 5 μL TdT + Reaction
buffer (Amersham), 2.5 μL dCTP (2 mM) were incu-
bated for 3 min at 94 °C, 1 μL of TdT was added and in-
cubated for 15 min at 37 °C, followed by an inactivation
step for 5 min at 65 °C. PCR was performed on the
cDNA tagged with polyC using the primer 5’Anc and
SPATA31_R. PCR products were purified using the rapid
PCR purification kit (Roche) and a second round of
Fig. 6 Increased UV sensitivity of mutated HFF cells. To assess the UVC sensitivity, we used the LDH cytotoxicity assay to measure the release of LDH
from damaged or dead cells. This is a very sensitive cell toxicity test [37] and [38]. a Differences between controls and mutated cells between the two
types of mutated cell lines, Cl1 (low) and Cl2 (high) and non-mutated control cells. b Differences between the low copy cell line HFF2450 and the high
copy cell line HFF2703. P-values of Student’s t test are indicated as * < 0.05, ** < 0.01, and *** < 0.001
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nested PCR was performed. The resulting PCR products
were cloned into the PGEM-T easy vector system (Pro-
mega) and insert sequences were determined by Sanger
based sequencing.
Other DNA Methods
All multiple sequence alignments were generated using
ClustalW [31, 32] Phylogenetic trees were generated
using MEGA [33] using the Kimura 2-parameter model
[34]. All positions containing alignment gaps and miss-
ing data were eliminated only in pairwise sequence com-
parisons (pairwise deletion option). NextGen sequencing
was done on Illumina MiSeq. The resulting sequencing
reads were first quality checked, PCR duplicates were re-
moved and then mapped by bwa mem [35] and the
mapped reads were visualized by IGV 2.3.55 [36]. Reads
with frameshift mutations around the CRISPR/Cas target
site were visually identified and counted.
Cell culture
HFF cells (HFF2703 (CRL-2703) and HFF2450 (CRL-
2450) purchased from ATCC) were grown in IMDM
(Cat No: 21980–065, Life Technologies, Paisley, U.K.;
GIBCO) and CV1, and L929 cells were grown in DMEM
(Cat No:41966–29, Life Technologies, Paisley, U.K.;
GIBCO) supplemented with 10% (vol/vol) FBS (PAC-
BIO) and 100U penicillin-streptomycin (Life Technolo-
gies; GIBCO). The culture was incubated at 37 °C
including 5% CO2.
Western blot analysis
Proteins were run on SDS-PAGE gels and transferred to
nitrocellulose membrane by electroblotting. Ponceau-S
(0.1% Ponceau-S (w/v) (Sigma), in 5% acetic acid) staining
was used to identify the location of the proteins on a
PVDF membrane. The membrane was blocked with 5%
milk powder or BSA, 0.1% Tween 20 (Sigma-Aldrich), for
15 h at 4 °C. Antiserum/antibody was diluted in PBS, 5%
milk powder or BSA, 0.1% Tween-20, and protein bands
were visualized using the enhanced chemiluminescence
(ECL) substrate kit (Amersham) and X-ray film sheets.
CRISPR/Cas targeting vector preparation
10 μg of pX260 or pX330 were digested with BbsI (NEB)
for 3 h at 37 °C. Digested pX260 or pX330 vectors were
purified by QIAEXII Extraction Kit (Qiagen) according
to manufacturers recommendation. Targeting guide
RNA sequence specific to exon1 of SPATA31 genes was
designed by using the CRISPR design tool (crispr.mi-
t.edu). Among 32 possible targeting guide RNAs,
“Fm_ex1_(GATATCCACACCCATGGTG)” was selected
as a guide RNA to avoid off-target possibilities. Among
98 possible target sides of Fm_ex_1, based on the
CRISPR Design tool, there were only three off-targets
within the exonic region outside of SPATA31 genes with
very low targeting score (less than 0.2). Complementary
oligo-nucleotides representing the target sequence were
annealed and phosphorylated according to [27]. The
ligation reaction was treated for 30 min with Plasmid-
Safe exonuclease (Epicenter) to prevent unwanted re-
combination products after the ligation reaction (Quick
ligation kit (NEB)) of purified vector and phosphorylated
and annealed oligos. 5 μL of the ligation reaction was
transformed to Top10 or Stbl3 competent cells (Life
Technologies; GIBCO). Positive clones were verified by
sequencing and DNA was isolated using the Maxiprep
plasmid DNA preparation kit (Qiagen).
Transfection of cells
Cells were seeded on T75 cm tissue culture flasks
(Thermo Fisher Scientific) before the transfection and
incubated overnight. Amaxa Nucleofactor (Lonza) pro-
grams for the transfection of the cells were optimized
according to manufacturers recommendation. We found
that program A033 is the best for most of the cells and,
therefore, all the transfections were performed using the
program A033. HFF cells (CRL-2703, ATCC) are trans-
fected with the mock and px330-FMex1 alone or to-
gether with px260-FMex1 constructs by using Amaxa
Basic Nucleofactor Kit for Primary Mammalian Epithe-
lial Cells (Cat No. VPI-1005). Cells were either directly
subcloned or subcloned after selection with puromycin
in mouse embryonic fibroblast (MEF) pre-seeded feeder
cell 96 well plates in a dilution ratio of 1 cell per well in
100 μL of IMDM medium ((Cat No: 21980–065,
GIBCO) 3 days after transfection. After approximately
5–6 weeks individual cell clones identified by colony for-
mation in the 96 well plates were successively subcul-
tured to 24, 48 and 6 well plates.
Antibody generation for Spata31 protein
Rabbit polyclonal antisera were raised against the pep-
tide (CHKSEKSRKPNLEKHE) located at the C-terminal
region of SPATA31 protein using keyhole limpet
hemocyanin (KLH) as a carrier protein. The peptide
synthesis (more than 80% purity) and injections to two
rabbits were performed by Pocono Rabbit Farm and La-
boratory (USA). Antibody titers were determined by an
ELISA assay and the specificity of the rabbit polyclonal
antibody against SPATA31 protein was tested both in west-
ern blot and immunofluorescence analysis (see Additional
File 9). 10 mL of 2nd and 3rd bleeds were purified against
the peptide by affinity purification (Affigel - BioRad).
LDH Cytotoxicity assay
We used the LDH cytotoxicity assay (Thermo Scientific
Pierce) to quantitatively measure lactate dehydrogenase
(LDH) released into the media from damaged cells as a
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biomarker for cytotoxicity according to manufacturers
recommendations [37] and [38]. Equal amount of cells
(about 1 million) were plated on a 5 cm plate. After 2 days
of incubation at 37 °C in a humidified incubator supple-
mented with 5% CO2, the medium was removed and cells
were immediately exposed to 200 J/m2 UVC light (Hoefer
UVC 500-UV cross linker machine (Amersham)). After the
UV treatment fresh medium was added and cells were in-
cubated for 24 h. Subsequently, after each 24 h of intervals
(24, 48 and 72 h) 1 ml aliquots of medium were taken from
each plate and frozen at−20 °C until the LDH cytotoxicity
assay was performed. The remaining medium was removed
and fresh medium was added for additional intervals. For
the comparison of mutation and natural CNV variations,
experiments repeated in two and three independent repli-
cates, respectively. Three replicates of 50 μL of growth
media (IMDM (see above)) taken from each sample at the
indicated time points were used according to the LDH
cytotoxicity assay kit protocol and absorbance measure-
ment (490–600 nm) was performed on a NanoQuant infin-
ite M200PRO (Tecan) using Magellan v7.0 software.
Immunofluorescence analysis
Cell lines for immunofluorescence analysis were grown
in 24-well plates including previously added cover slips
to each well. The growing media were removed and the
cells (either treated or transfected) were directly fixed
with 0.5 mL of −20 °C cold methanol or PBS/1.5% para-
formaldehyde (PFA) for 10 min at room temperature
(RT) followed by−20 °C cold methanol for 10 min
at −20 °C. Cells were washed three times with PBS and
additionally washed with 1 mL of PBS/0.1% saponin
(Sigma-Aldrich) by incubating for 20 min at RT on a
shaker in slow motion (50 rpm). The wash buffer was
removed and cells were immediately blocked by adding
PBS/0.1% saponin/3% BSA (bovine serum albumin,
fraction V, Sigma Aldrich) and incubated for 1 h at RT in
24-well plates. Coverslips were incubated with 0.25 mL of
PBS/0.1% saponin in a humified environment for 1 h at
RT or overnight at 4 °C. Cells were washed 3× with
1 mL of PBS/0.1% saponin. After washing, coverslips
were incubated with the appropriate secondary antibody
(Alexa Fluor® 488, 546 or 594 (Molecular Probes, Life
Technologies; GIBCO)) dilutions (1:2000) in a humidified
environment for 1 h at RT in the dark. Cells were washed
3× with 1 mL of PBS/0.1% saponin for 20 min at RT on a
shaker in slow motion (50 rpm). Finally, coverslips were
put onto a microscope slide with 10 μL of ProLong®
Gold Antifade Mountant, which contains DAPI (Cat
No: P36941, Molecular Probes, Life Technologies;
GIBCO). After overnight incubation, cells were ob-
served with a Leica (DM5000) confocal fluorescence
microscope, using the Leica software (Leica Application
Suite LAS X) for photography and analysis. Of note, we
noticed a slight variation in the subcellular localization
of SPATA31 proteins depending on treatment condi-
tions. First, SPATA31 is very sensitive to light exposure
and we needed to keep the cells in the dark and fix them
very fast for the UV response experiments. Second, when
methanol at −20 °C was used for the initial fixation,
most of the immunofluorescence signal was detected in
the nucleus, whereas when we fixed the cells only with
4% PFA the signal was seen both at the cytoplasmic
membrane and the nucleus. Methanol is known to
solubilize membrane bound proteins, i.e. this may have
caused the loss of membrane signal under the methanol
fixation conditions. Therefore, we prefer to use initial
fixation of PBS/1.5% paraformaldehyde (PFA) for
10 min at room temperature (RT) followed by −20 °C
cold methanol for 10 min at −20 °C.
DIGITAL PCR for copy number detection
The human 1000 genome sample data were used ac-
cording to the Fort Lauderdale Agreement, January 2003
(http://www.1000genomes.org/data#DataUse). We used
the genomic DNA panels for a subset of individuals that
were also used in the 1000 Genomes Project. Specific-
ally, we genotyped a total of 366 samples from the
MGP00001 (Finnish in Finland), MGP00002 (Han Chin-
ese South), MGP00008 (Luhya in Webuye, Kenya) and
MGP00013 (Yoruba in Ibadan, Nigeria) panels from the
NHGRI Repository at Coriell. The sample names are
listed in Additional File 15 along with the estimated
copy number states for these genomes. PCR reaction
mixtures were prepared from 10 μL of 2x ddPCR Super-
mix for Probes (Bio-Rad, Hercules, CA, USA) mixed
with HindIII restriction enzyme, 1 μL of the EIF2C1
primers with a fluorescent labeled probe (1 μL of the
SPATA31 primers with a fluorescent labeled probe), 1 ng
of DNA template and 6 μL of molecular grade water to
make a 20 μL final volume (see Additional File 16 for
the primer and probe list). This reaction mixture was
prepared in an Eppendorf 96-well twin.tec PCR plate
and then loaded into the Automated Droplet Generator
(Bio-Rad, Hercules, CA, USA) to generate oil droplets in
each well of the plate containing 20 μL of the reaction
mixture. After droplets were generated, the plate was
sealed with a pierceable foil heat seal using PX1™ PCR
Plate Sealer (Bio-Rad, Hercules, CA, USA) and then
placed on a thermal cycler for amplification. Thermal
cycling conditions were as follows: 95 °C for 10 min
(1 cycle), 94 °C for 30 s (ramp rate 2.5 °C/s) and 56 °C
for 60 s (ramp rate 2.5 °C/s) (40 cycles), 98 °C for
10 min (1 cycle), and 12 °C hold. After PCR, the 96-well
PCR plate was loaded on the QX100™ Droplet Reader
(Bio-Rad, Hercules, CA, USA), which reads the droplets
from each well of the plate. The data obtained were ana-
lyzed using QuantaSoft™ analysis software provided with
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the QX100™ Droplet Reader. We scored the copy num-
bers by measuring the concentration of the target,
SPATA31, relative to the concentration of the reference
for population analysis, EIF2C1.
In silico estimation of SPATA31 copy number in different
lineages of primates
To estimate the copy number of SPATA31 sequences
across different primate genomes, we utilized whole gen-
ome sequencing data of available genomes. Specifically,
we analyzed nine modern humans genomes (from the
1000 Genomes Project) from different ethnicities. We also
downloaded the genome data of the 45,000 year old mod-
ern human - Ust_Ishim from Siberia [39]. In addition, we
compiled data from Denisovan [40], Altai Neandertal [41]
genomes both of which have high read-depth as compared
to most ancient genomes. For nonhuman primates, we
used data from Gokcumen at al., [25], which includes five
chimpanzees, five orangutans, five rhesus monkey ge-
nomes. We used these data to record the read depth of
the SPATA31 homologous sequences in these genomes
(samtools v1.3) [42]. Primate reference genomes do not
reflect the full scope of copy number of SPATA31, i.e.,
some of the SPATA31 sequences may not be represented
in the reference genomes. We surmised that even if there
is one copy of the SPATA31 sequence, the reads from
other SPATA31 sequences will map to that reference loca-
tion. Based on this we summed up the total read-depth
and normalized the resulting read-depth with the overall
read-depth observed in the specific genome. This pipeline
allowed us to comparatively estimate the total copy num-
ber of SPATA31 sequences across and within species
(Additional File 2).
Additional files
Additional file 1: Phylogeny of SPATA31 proteins. Neighbor-Joining tree
[43] of SPATA31 protein sequences from human (capital letters) and
mouse (small letters); bootstrap values (1000 replicates) are shown next
to the branches [44]. The tree includes the distant gene families D and E.
(PDF 362 kb)
Additional file 2: Copy number estimates of SPATA31 in different
lineages of primates. For each genome, the read depth at all putative
SPATA31 sites were recorded from the primary genome sequence reads,
summed up, and normalized by genome-wide read depth to obtain the
haploid copy number estimation (y-axis). The genome samples analyzed
are listed on the x-axis, including a Denisovan, a Neandertal, a Ust_Ishim,
nine modern humans, five chimpanzees, five orangutans, five rhesus
monkeys. Samples are color coded according to their species. Individual
ancient genomes were also color-coded. The color-coding is shown on
the right of the plot. See Methods for the details of the SPATA31 copy
number estimates in primates. (PDF 150 kb)
Additional file 3: Promoter comparisons between mouse Spata31 and
human SPATA31A/C genes. Overall schematic comparison with the
experimentally determined transcriptional start sites indicated with
respect to the ATG start codon. To identify the transcription initiation
sites, we performed 5’RACE (rapid amplification of cDNA ends). This
yielded an initiation site 38 bp upstream of the start codon for SPATA31A,
which is consistent with the canonical start site present in sequence
databases (note: it differs by the addition of only 18 additional bp when
compared to the reference mRNA sequence (NM_001085452) for
SPATA31A1. Compared to mouse, we found that LINE/L1 and other
elements inserted into the promoter region of SPATA31 genes, creating
different upstream regions for A and C types. Further, the type A genes
acquired a (CCCCCT)n simple repeat which provides potential Sp1
binding sites, present within the promoter region, which can be traced
to the progenitor of humans, gorillas and chimpanzees (compare Fig. 2).
(PDF 393 kb)
Additional file 4: Alignment of SPATA31 proteins. Alignment of mouse
and human SPATA31A/C proteins by Clustal-W [31] and [32]. BoxShade
server (http://www.ch.embnet.org/software/BOX_form.html) was used to
highlight similar (grey) and identical (black) amino acids. Identified domains
corresponding to the ones shown in Fig. 3 are indicated. (PDF 126 kb)
Additional file 5: Table with details of domains found in SPATA31
proteins. (XLSX 9 kb)
Additional file 6: Alignment of SPATA31 protein with CRY2 and EBV-
BPLF1 proteins. The figure shows the alignment of SPATA31A1 (Q5TZJ5-1)
protein with CRY2 (Q49AN0-1) (Top) and ENV-BPLF1 (P03186) (bottom)
proteins. Similar (gray) and identical (black) amino acids are highlighted by
using boxshade (http://www.ch.embnet.org/software/BOX_form.html).
Alignment was performed by using Clustal-w and manually edited and only
the region showing highest homology/similarity region is shown (starting
from the amino acid position 166 of SPATA31A1) [31]. The overall calculated
identity and similartiy between SPATA31A1 and CRY2 protein within the
given window of alignment is 15% and 23%, and between SPATA31A1 and
EBV-BPLF1 protein is 17% and 28%, respectively. Identity and similarity was
calculated by GeneDoc software (version 2.7.000). (PDF 53 kb)
Additional file 7: Co-localization of SPATA31 with CRY2 protein in HFF
cell line. Immunofluorescence analysis of SPATA31 protein in HFF cells
showing the co-localization of the SPATA31 protein with CRY2 protein.
Cells were stained with a 1:100 dilution of SPATA31 antibody (red) and
CRY2 antibody (Abcam, 1;250) (green) and merged (yellow). The nucleus
is visualized by DAPI staining (blue). Note that these cells had been
exposed to light and not syncronized, i.e. the nucleolar staining is not so
prominent. (PDF 1403 kb)
Additional file 8: Quantitative expression analysis of the SPATA31 gene
family in human. Quantitative real time PCR analysis on Human SPATA31
genes based on cDNA from brain, testis, liver, kidney, heart, lung, thymus,
spleen and cerebellum tissues (RNAs obtained from Clontech). PCR primers
were designed to amplify the highly conserved region within the last long
coding exon. The UBE1 gene was used as control. (PDF 1306 kb)
Additional file 9: Tests of SPATA31 antibody specificity. A) Test for
antibody specificity on bacterially expressed SPATA31 protein. The C-
terminal peptide of SPATA31 (starting at aa position 1122, 3362 bp
from the M/ATG start codon) was cloned in reverse and forward
orientation into the PGEX-4 T1 bacterial expression vector (see
scheme) and transformed into Bl21 E.coli cells for expression analysis.
Coomassie blue staining (above) and Western blot analysis (below) of
IPTG induced (1 mM and 0.1 mM for 3 h) cells are shown. A strong
antibody signal occurred only for the forward orientation under strong in-
duction. B) Western blot of comparative analysis of SPATA31 protein, stained
with affinity purified polyclonal SPATA31 antibody (1:500), from human (HFF
cells), macaque cells (CV1) and mouse cells (L929). Cells were fractionated
by Qproteom (Qiagen) subcellular fractionation kit, loaded on a 4–15%
gradient PAGE-SDS gel (Biorad) and electro-blotted onto a PVDF membrane.
Note that the picture shows the cytoplasmic fraction, since this yielded a
stronger signal. Mouse monoclonal α-tubulin antibody (Sigma 1:1000) was
used as loading control. The predicted gene lengths of the protein coding
regions of SPATA31 genes were 157kD for the A type (A1) and 130kD for the
C type (C1) respectively. The detected size on the western blots shows
protein bands around 170–200 kD, probably due to post-translational
modifications. C) CV1 cells were transiently transfected with C-terminally
Flag-tagged SPATA31A1 (exon4 only, lacking a nuclear localization signal). 24 h
after transfection, cells were fixed with cold (4 °C) 1.5% paraformaldehyde at
room temperature for 10 min, followed by fixation with Methanol−20 °C for
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10 min in−20 °C and stained with DAPI (blue), a monoclonal antibody against
Flag-tag (anti-flag-M2 (Sigma, 1:500) (green) and the polyclonal antibody
against SPATA31 protein (red). The polyclonal antibody stains both, the protein
from cytoplasm expressed Exon4 construct, as well as the endogenous nuclear
SPATA31 protein. The scheme of the constructed mammalian expression vec-
tor map (pFlag5.1 (Sigma)) is presented below. The figures are merged and
magnification is 63X. (PDF 2649 kb)
Additional file 10: Localization of SPATA31 protein in spindle assembly
during mitosis. Antibody staining of human primary fibroblast (HFF) cells
(63x). Nuclei in the first panel are stained with DAPI (blue), SPATA31 staining
is shown in the second panel (red). In the third panel, the green staining in
the 63x pictures is cellular cytoskeleton detected with an antibody against
tubulin and as a marker for spindle assembly. (PDF 3209 kb)
Additional file 11: Expression and localization of SPATA31 protein in
human tissues. Immunohistochemistry staining of SPATA31 protein in fresh
frozen tissue sections of Lung CF (A), Sinus (B) and Tonsil allergic (C)
(obtained from Swiss Institute of Allergy and Asthma Research, Davos,
(SIAF)). Pre-immune_SPATA31, Pre_DAPI (pre-immune and DAPI merged),
SPATA31 (1st bleed whole serum, 1:500), SPATA31/DAPI (SPATA31 antibody
and DAPI merged). DAPI was used to visualize the nuclei. (PDF 20132 kb)
Additional file 12: Quantification of SPATA31 re-localization within the nu-
cleus upon UVC treatment of HFF cells. The figure depicts % of co-localization
between SPATA31 and PER2 antibody within the nucleus upon stimulation
with different UVC exposure times (horizontal). Cells were counted from a win-
dow of 63X randomly chosen confocal images, containing approximately 20
cells, assessed whether co-localization of SPATA31 in the nucleolus with PER2
occurs upon different UVC treatments. Cells were synchronized for 3 days by
replacing IMDM growth medium (including 10% FBS) with serum free IMDM
growth media. After 3 days of incubation, serum free growth medium was re-
placed with IMDM growth medium including 10% FBS. Six hours after
addition of serum containing growth media, the growth medium was com-
pletely removed from the plates and the cells were irradiated with 0 (control),
10, 20, 40, 80 and 200 J/m2 UVC (See methods). After the appropriate UVC ir-
radiation, fresh IMDM growth medium containing FBS was added to each
plate and cells were kept 1 h of additional incubation in 37 °C including 5%
CO2. After 1 h of additional incubation IMDM growth media was removed
and cells were fixed immediately with−20 °C precooled 100% methanol for
10 min in a−20 °C freezer in dark conditions. Methanol was then removed
and the cells were subjected to immunofluorescence analysis. All UV treat-
ments showed a reduced number of cells with co-localization of SPATA31 in
nucleolus with PER2 in different percentages. All differences to control were
significant (P< 0.01, unpaired two-tailed t test). (PDF 49 kb)
Additional file 13: Experimental design for CRISPR/Cas targeted
disruption SPATA31 genes in human. Scheme for the design of the targeted
disruption of the open reading frames of SAPATA31 type A and type C
genes (including alternative exons) by using CRISPR/Cas mediated
mutagenesis [27]. Six single cell clones were isolated and identified to have
different numbers (3-low (S5, S7, S12) and 3-high (S6, S8, S11)) of frame shift
mutations. See Additional File 14 for details of this analysis. (PDF 4556 kb)
Additional file 14: Frame Shift Mutation analysis. The upper table
provides the number of reads with frameshifts per number of reads for
the different annotated SPATA31 genes, the lower table provides the
respective percentages. (PDF 44 kb)
Additional file 15: List of CNVs of SPATA31 genes in individuals from
Chinese, Finnish, Yoruba and Kenyan populations (PDF 88 kb)
Additional file 16: PCR conditions and Primer List. PCR was performed
in 20 μL reactions composed of 0.8 μL of a 10 mM dilution of the
forward primer and reverse primer, 10 μL of Roche (11636103001) PCR
Master Mix. The following PCR conditions were used (A): 3 min at 95 °C,
followed by 40 cycles at 95 °C for 30 s, 55 °C 30 s, and 72 °C for 30 s
followed by 7 min at 72 °C. The following real-time PCR conditions (B)
were used: 3 min at 95 °C, followed by 50 cycles at 95 °C for 15 s, 55 °C
20 s, and 72 °C for 20 s elongation cycle. (PDF 93 kb)
Abbreviations
CNV: Copy Number Variation; EBV: Epstein Barr Virus; EGF: Epidermal Growth
Factor; HFF: Human Foreskin Fibroblast; KLH: Keyhole Limpet Hemocyanin;
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